Cytiva Partnership: Transforming Biotechnology in Turkey
TCT Sağlık Teknolojileri is proud to partner with Cytiva, a global leader in innovative bioprocessing technologies, to revolutionize the field of cell and gene therapy manufacturing in Turkey. This collaboration represents a critical step toward bringing advanced therapeutic solutions to the region, enabling TCT to enhance its infrastructure and expand its capabilities.
Cutting-Edge Biomanufacturing Solutions with FlexFactory™
As part of this strategic alliance, TCT has integrated Cytiva’s FlexFactory™ platform, a modular and scalable biomanufacturing solution. This cutting-edge platform incorporates advanced instruments like:
- ReadyToProcess WAVE™ bioreactors for flexible and scalable cell culture processes.
- ÄKTA™ chromatography systems for precise purification of biomolecules.
- Xcellerex™ XDR bioreactors for large-scale production of therapies.
- Sefia™ platform for closed-loop, automated cell processing including isolation, washing, and formulation.
These systems, supported by Chronicle™ automation software, ensure compliance, efficiency, and high-quality output, streamlining the development of advanced treatments such as CAR-T therapies, mRNA-based therapies, and gene editing technologies.
Technology Transfer and Local Production
The Cytiva partnership facilitates seamless technology transfer, equipping TCT with the expertise and tools to locally manufacture licensed therapies at global standards. This collaboration ensures that Turkish patients have access to innovative treatments while enhancing the country’s biotechnology infrastructure. By leveraging Cytiva’s bioprocessing solutions, TCT can scale up operations rapidly and maintain the highest quality in therapeutic development.
Building Turkey’s Biotechnology Ecosystem
This partnership with Cytiva strengthens TCT’s role as a catalyst for biotechnology innovation in Turkey. By integrating advanced technologies and fostering local production capabilities, TCT is paving the way for the creation of a robust biotechnology ecosystem. This effort not only accelerates the availability of next-generation therapies but also positions Turkey as a global hub for biomanufacturing and advanced healthcare solutions.
A Vision for Excellence in Healthcare
Through its collaboration with Cytiva, TCT Sağlık Teknolojileri is driving innovation and setting new standards for excellence in biotechnology. This strategic partnership underscores TCT’s mission to make Turkey a leader in biotechnology and advanced therapeutic solutions, improving patient outcomes and addressing critical healthcare needs locally and globally.